Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05066503 · ClinicalTrials.gov registry record · NA
Nutritional Therapy for Delirium in Elderly Hospitalized Subjects
A NA study of Subacute Delirium, sponsored by University of Arkansas.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05066503: Recruiting NA study of Subacute Delirium, sponsored by University of Arkansas.
NCT05066503 is a NA study of Subacute Delirium that is actively recruiting participants, run by University of Arkansas. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05066503, a NA study of Subacute Delirium, is actively recruiting participants, sponsored by University of Arkansas.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators have developed a proprietary blend of amino acids that they think will help to prevent or reduce the severity of delirium in older adults (60 years and older) who are hospitalized for certain infections. In this study, up to 60 people will be enrolled.20 will be asked to drink this blend twice a day for up to 4 days, and 20 will receive standard treatment in the hospital for the same time period. The other 20 subjects will be non-delirious control subjects who do not consume any study products.
Primary Outcome
CAM-S and 4 AT is a tool to determine and quantify delirium. Subjects in the non-control arms will undergo this test twice each day. The score ranges from 0-7, with lower numbers being better (little to no signs of delirium).
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT 260279 active study product
Study Locations (1)
Arkansas
- UAMS Center on Aging - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-11-16 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT05066503 shows while recruiting
NCT05066503 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Subacute Delirium appearing as the primary indexed condition, and to 1 intervention - of which 260279 active study product is the first listed.
NCT05066503 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT05066503 about?
NCT05066503 is a clinical study titled "Nutritional Therapy for Delirium in Elderly Hospitalized Subjects". The investigators have developed a proprietary blend of amino acids that they think will help to prevent or reduce the severity of delirium in older adults (60 years and older) who are hospitalized for certain infections. In this study, up to 60 people will be enrolled.20 will be asked to drink this...
What is the current status of trial NCT05066503?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2020-11-16. Estimated completion is 2027-01.
What conditions does trial NCT05066503 study?
This clinical trial studies the following conditions: Subacute Delirium.
What interventions are being tested in trial NCT05066503?
The interventions under investigation include: 260279 active study product (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05066503?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05066503 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05066503's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI